Entrada Therapeutics, Inc. (TRDA)

Entrada Therapeutics Revenue

Entrada Therapeutics had revenue of $20.56M in the quarter ending March 31, 2025, a decrease of -65.23%. This brings the company's revenue in the last twelve months to $172.22M, up 5.74% year-over-year. In the year 2024, Entrada Therapeutics had annual revenue of $210.78M with 63.38% growth.

• Revenue (ttm): $172.22M
• Revenue Growth: +5.74%
• P/S Ratio: 1.91
• Revenue / Employee: $941,093
• Employees: 183
• Market Cap: 310.96M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	210.78M	81.77M	63.38%
Dec 31, 2023	129.01M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.